How can I explain to a 19‑year‑old patient, originally diagnosed with bipolar II disorder and now suspected of borderline personality disorder, who is on Caplyta (lumateperone) and lamotrigine and has depression, hypomania, and suicidal ideation, that medications may not fully treat BPD but can still help her mood symptoms?

Explaining Medication Benefits in Suspected BPD with Mood Symptoms

You are correct—medications can meaningfully help your patient's depression and mood instability even if BPD is present, because she has clear mood disorder symptoms that respond to pharmacological treatment regardless of the personality disorder diagnosis. 1

The Core Message to Convey

Medications target specific symptom domains (depression, mood instability, suicidal ideation) rather than treating "BPD" as a whole entity. The American Academy of Child and Adolescent Psychiatry emphasizes that pharmacotherapy in BPD should be targeted at specific comorbid conditions like depression and anxiety, not at core BPD symptoms themselves. 1 This distinction is crucial for your patient to understand.

Key Points for Your Discussion

• Her depressive symptoms and mood instability are real psychiatric conditions that warrant medication treatment, whether they occur in the context of bipolar II, BPD, or both. 1

• Lamotrigine has demonstrated efficacy for mood stabilization and affective instability in both bipolar disorder and BPD. Multiple studies show lamotrigine reduces emotional dysregulation and impulsivity in BPD patients, with one Cochrane review identifying it as among the most beneficial mood stabilizers for BPD symptoms. 2, 3

• Caplyta (lumateperone) is FDA-approved for bipolar depression and addresses her depressive symptoms regardless of whether BPD is also present. 1

Addressing Her Specific Concerns

Why Medications Still Work

• The presence of BPD does not negate the existence of treatable mood disorder symptoms. The Annual Review of Clinical Psychology specifically recommends targeting comorbid depression and anxiety in BPD patients with appropriate pharmacotherapy. 1

• Many patients carry both diagnoses—bipolar disorder and BPD frequently co-occur, especially in adolescents and young adults, sharing features like emotional dysregulation, affective instability, and impulsivity. 4 This overlap means treating the mood component remains essential.

• Her history of hypomania suggests a mood disorder component that is biologically based and medication-responsive. The American Academy of Child and Adolescent Psychiatry notes that approximately 20% of youth with major depression eventually develop manic episodes, and her hypomanic symptoms warrant mood stabilizer treatment. 4

What Medications Can and Cannot Do

Medications effectively treat:

• Depressive episodes 1
• Mood instability and affective dysregulation 2, 3
• Impulsivity 3
• Suicidal ideation (indirectly through mood stabilization) 1

Medications have limited impact on:

• Core interpersonal instability characteristic of BPD 1
• Identity disturbance 1
• Chronic feelings of emptiness 1

The Evidence Supporting Her Current Regimen

Lamotrigine Specifically

• Lamotrigine shows effectiveness for affective instability in BPD patients, with studies demonstrating significant improvement in Clinical Global Impression scores. One retrospective review found all but one patient improved from severely ill (CGI 5-6) to borderline mentally ill or normal (CGI 1-2) on lamotrigine 50-200 mg/day. 5

• A Cochrane systematic review identified lamotrigine as one of the most beneficial mood stabilizers for BPD symptoms, particularly for mood stabilization and reducing emotional dysregulation. 3

• However, one large RCT (276 participants) found no significant benefit of lamotrigine over placebo at 52 weeks, though adherence was notably low (only 36% still taking lamotrigine at study end). 6 This highlights that medication effectiveness requires consistent use.

Caplyta (Lumateperone)

• Caplyta is FDA-approved for bipolar depression and addresses her depressive symptoms through its unique mechanism targeting serotonin, dopamine, and glutamate systems. 1

Practical Communication Strategy

Frame the Conversation This Way

"The therapist is right that psychotherapy—specifically Dialectical Behavior Therapy—is the primary treatment for BPD. But that doesn't mean your medications aren't working or aren't needed." 1

"Think of it this way: You have depression and mood instability that cause you significant distress. These symptoms respond to medication whether they're part of bipolar disorder, BPD, or both. The medications aren't treating your 'personality'—they're treating specific brain chemistry imbalances that cause depression and mood swings." 1

"Your lamotrigine helps stabilize your mood and reduce the intensity of emotional swings. Your Caplyta targets the depressive symptoms. Both of these are legitimate medical treatments for real symptoms you're experiencing." 2, 3

Address the Diagnostic Uncertainty

• Explain that bipolar II and BPD can coexist and share overlapping features, particularly in young adults. The American Academy of Child and Adolescent Psychiatry notes that bipolar disorder in adolescents is often associated with features of borderline personality disorder. 4

• Emphasize that the diagnostic label matters less than treating her current symptoms effectively. Whether her mood instability stems primarily from bipolar II, BPD, or both, the treatment approach for the mood component remains similar. 1

• Point out that her history of hypomania is a strong indicator for continuing mood stabilizer treatment regardless of the BPD diagnosis. Hypomanic episodes are not a feature of BPD alone and suggest an underlying mood disorder component. 4

The Treatment Plan Going Forward

Medication Component

• Continue both lamotrigine and Caplyta, as they target different symptom domains (mood stability and depression, respectively). 1, 2

• Monitor closely for medication adherence, as the Annual Review of Clinical Psychology notes adherence issues are common in BPD and may benefit from Brief Motivational Intervention. 1

• Set realistic expectations: medications will help with mood symptoms and depression but won't resolve interpersonal difficulties or identity issues. 1

Psychotherapy Component

• Strongly recommend Dialectical Behavior Therapy (DBT), which the American College of Physicians identifies as first-line treatment for BPD. DBT includes skills training for emotional regulation, distress tolerance, interpersonal effectiveness, and mindfulness. 1

• Explain that DBT and medications work synergistically—medications stabilize the biological mood component while DBT teaches skills to manage emotional dysregulation and interpersonal difficulties. 1

• A standard DBT course involves 12-22 weekly sessions, with longer duration considered for more severe presentations. 1

Addressing Suicidal Ideation

• Implement crisis response planning with clear identification of warning signs and coping strategies. 1

• Both bipolar disorder and BPD carry high suicide risk; the American Academy of Child and Adolescent Psychiatry emphasizes thorough assessment of suicidality in both conditions. 4

Common Pitfalls to Avoid

• Do not discontinue mood stabilizers based solely on a BPD diagnosis. Her history of hypomania and current mood instability warrant continued pharmacological treatment. 4

• Avoid the false dichotomy of "either bipolar II or BPD." Both diagnoses can coexist, and treating the mood component remains essential regardless. 4

• Do not allow the BPD diagnosis to create therapeutic nihilism. While BPD is challenging to treat, targeted pharmacotherapy for mood symptoms combined with evidence-based psychotherapy offers meaningful improvement. 1

• Monitor for antidepressant-induced mood elevation, as this would further support an underlying bipolar component. The American Academy of Child and Adolescent Psychiatry notes that antidepressant-induced mania strongly suggests bipolar disorder. 4

Reassessment Strategy

• Schedule regular follow-up to monitor treatment response and diagnostic clarity over time. The American Academy of Child and Adolescent Psychiatry recommends reassessing diagnosis periodically as the clinical picture evolves. 4

• Use a life chart to track mood patterns, episode duration, and treatment responses longitudinally. This helps distinguish episodic mood changes (suggesting bipolar) from chronic emotional dysregulation (suggesting BPD). 4

• Obtain detailed family psychiatric history, particularly for mood disorders and bipolar disorder, as first-degree relatives have 4-6 fold increased risk. 4 A positive family history would further support continuing mood stabilizer treatment.

Your clinical instinct is sound: continue the medications that are targeting her mood symptoms while ensuring she engages in evidence-based psychotherapy for the personality disorder features. 1 The two approaches are complementary, not mutually exclusive.